| abstract |
Combination of at least two direct-acting antiviral agents, ribavirin but not interferon, for use of HCV treatment. # The present invention presents combinations of antiviral agents for use in therapies with ribavirin but without interferon in the treatment of HCV. Preferably, the treatment is for a short time, such as no more than 12 weeks. In one aspect, the use of combinations of antiviral agents in therapies comprises administering at least two direct-acting antiviral agents and ribavirin to a subject with HCV infection. |